Can Ertapenem Be Used With Penicillin?
Yes, ertapenem can be co-administered with penicillins, and this combination is specifically recommended in certain clinical scenarios, particularly for severe staphylococcal infections and necrotizing fasciitis.
Clinical Context and Evidence
Established Guideline Support
The combination of ertapenem with anti-staphylococcal penicillins (such as nafcillin or oxacillin) or cefazolin is explicitly recommended in IDSA guidelines for necrotizing fasciitis. For mixed necrotizing infections, ertapenem 1g daily IV can be used as a single agent, or alternatively, combination regimens including penicillins are appropriate 1, 2.
For complicated intra-abdominal infections, guidelines list both ertapenem and various penicillin-based regimens (ampicillin-sulbactam, piperacillin-tazobactam) as acceptable options, though typically as alternatives rather than concurrent therapy 3.
Emerging Evidence for Combination Therapy
Recent research demonstrates that combining ertapenem with anti-staphylococcal beta-lactams (penicillin M, nafcillin, oxacillin, or cefazolin) shows clinical benefit for persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia 4, 5. In a multicenter case series of 35 patients with complicated MSSA bacteremia, dual therapy resulted in median bacteremia clearance within 2 days, with only 5.7% serious adverse events 4. A pediatric case report documented successful treatment of vertebral osteomyelitis with persistent bacteremia using this combination 5.
The mechanism may involve immunomodulation: ertapenem appears to stimulate interleukin-1β release from peripheral blood monocytes, which may enhance bacterial clearance beyond simple antimicrobial synergy 6.
Safety Considerations
Cross-Reactivity in Beta-Lactam Allergy
The historical concern about carbapenem cross-reactivity with penicillins is largely unfounded. A prospective study of 49 patients with confirmed IgE-mediated penicillin allergy (positive skin tests) found that 35 of 36 patients (97%) tolerated full-dose ertapenem challenge after negative skin testing 7. This demonstrates cross-reactivity rates below 3%, far lower than the previously cited 47% rate for imipenem.
Drug Interactions
The FDA label explicitly warns against combining ertapenem with valproic acid/divalproex sodium due to reduced valproic acid concentrations and increased seizure risk 8. However, no contraindication exists for concurrent use with penicillins.
Probenecid should not be co-administered with ertapenem as it increases ertapenem plasma concentrations 8.
Practical Recommendations
When to Consider Combination Therapy
- Persistent MSSA bacteremia despite appropriate anti-staphylococcal therapy
- Complicated staphylococcal infections (endocarditis, osteomyelitis, deep-seated abscesses) where source control is not immediately feasible
- Necrotizing fasciitis with mixed or staphylococcal etiology
Dosing
- Ertapenem: 1g IV daily (infused over 30 minutes)
- Anti-staphylococcal penicillin: Standard dosing (e.g., nafcillin 1-2g IV every 4 hours)
- Adjust ertapenem for renal impairment (CrCl ≤30 mL/min requires dose reduction to 500mg daily) 8
Critical Pitfalls to Avoid
- Do not mix or co-infuse ertapenem with other medications in the same IV line 8
- Do not use dextrose-containing diluents for ertapenem reconstitution 8
- Avoid this combination in patients on valproic acid—consider alternative antibiotics 8
- Monitor for encephalopathy, particularly in critically ill patients or those with renal impairment 4
- In critically ill patients with preserved renal function (CrCl ≥60 mL/min), divided dosing of ertapenem may be more optimal than once-daily dosing for both efficacy and neurotoxicity prevention 9